XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025

Realtime	Geld	Brief	Zeit
	10,800	11,100	22:54

Realtime

Geld

Brief

Zeit

10,800

11,100

22:54

XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025

The following instruments on XETRA do have their first trading 24.06.2025
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.06.2025

Aktien

1 NL0015002J37 JBS N.V.
2 AU0000400616 Virgin Australia Holdings Ltd.
3 US1421521071 Caris Life Sciences Inc.
4 US15117F8804 Cellectar Biosciences Inc.
5 KYG2545C1042 Crescent Biopharma Inc.

6 CA3194101067 First Canadian Grahite Inc.
7 KYG3472Y1199 FIH Mobile Ltd.
8 CA75103L3092 Rakovina Therapeutics Inc.

Anleihen/ETF

1 XS3102006031 Al Mi'yar Capital S.A.
2 EU000A4EB337 Europäische Union
3 NO0013289397 Gondola Midco AS
4 US594972AN17 MicroStrategy Inc.
5 XS3094548123 OTP Jelzálogbank Részvénytársaság
6 XS3098982815 SNB Funding Ltd.
7 USN88808AE50 Trivium Packaging Finance B.V.
8 US92939UAP12 WEC Energy Group Inc.
9 XS2903447519 Hyundai Capital America
10 XS3079581479 Intesa Sanpaolo S.p.A.
11 XS3077018714 Nexi S.p.A.
12 DE000HEL4AF3 Landesbank Hessen-Thüringen Girozentrale
13 IE000CO3P697 First Trust Vest U.S. Equity Max Buffer UCITS ETF
14 IE000HFBJ0U0 First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF

Zeit	Aktuelle Nachrichten
13.08.	Caris Life Sciences stock price target raised to $37 by BofA on strong ASP growth
13.08.	Caris Life Sciences stock price target raised to $45 from $38 at BTIG
13.08.	BTIG hebt Kursziel für Caris Life Sciences auf 45 $ an
13.08.	Caris Life Sciences stock price target raised to $40 from $33 at Evercore ISI
13.08.	Evercore ISI hebt Kursziel für Caris Life Sciences auf 40 US-Dollar an

Zeit

Aktuelle Nachrichten

13.08.

Caris Life Sciences stock price target raised to $37 by BofA on strong ASP growth

13.08.

Caris Life Sciences stock price target raised to $45 from $38 at BTIG

13.08.

BTIG hebt Kursziel für Caris Life Sciences auf 45 $ an

13.08.

Caris Life Sciences stock price target raised to $40 from $33 at Evercore ISI

13.08.

Evercore ISI hebt Kursziel für Caris Life Sciences auf 40 US-Dollar an

Zeit	Aktuelle Nachrichten
Mo	Cellectar Biosciences, Inc. - S-1, General form for registration of securities
10.10.	Cellectar Biosciences beschafft 5,8 Mio. US-Dollar über Optionsscheine
07.10.	Cellectar Biosciences enters into agreements to raise $5.8M
07.10.	Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
06.10.	Cellectar Biosciences, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

Cellectar Biosciences, Inc. - S-1, General form for registration of securities

10.10.

Cellectar Biosciences beschafft 5,8 Mio. US-Dollar über Optionsscheine

07.10.

Cellectar Biosciences enters into agreements to raise $5.8M

07.10.

Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million

06.10.

Cellectar Biosciences, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
02.10.	XFRA C68: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
27.08.	Stifel reiterates Buy rating on Crescent Biopharma stock at $28 target
25.08.	Jefferies startet Coverage für Crescent Biopharma mit Kaufempfehlung und hohem Kursziel
25.08.	Jefferies initiates coverage on Crescent Biopharma stock with Buy rating
31.07.	Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights	Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.10.

XFRA C68: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

27.08.

Stifel reiterates Buy rating on Crescent Biopharma stock at $28 target

25.08.

Jefferies startet Coverage für Crescent Biopharma mit Kaufempfehlung und hohem Kursziel

25.08.

Jefferies initiates coverage on Crescent Biopharma stock with Buy rating

31.07.

Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring...
► Artikel lesen

Zeit	Aktuelle Nachrichten
24.09.	FIH (02038): NEXT DAY DISCLOSURE RETURN
18.09.	FIH (02038): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...
18.09.	FIH (02038): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...
18.09.	FIH (02038): INTERIM REPORT 2025
12.09.	FIH (02038): NEXT DAY DISCLOSURE RETURN

Zeit

Aktuelle Nachrichten

24.09.

FIH (02038): NEXT DAY DISCLOSURE RETURN

18.09.

FIH (02038): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...

18.09.

FIH (02038): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...

18.09.

FIH (02038): INTERIM REPORT 2025

12.09.

FIH (02038): NEXT DAY DISCLOSURE RETURN

Zeit	Aktuelle Nachrichten
00:18	First Canadian Graphite Inc: First Canadian talks Chinese export restrictions
Do	First Canadian Graphite Inc.: First Canadian Graphite well positioned to Capitalize on China's Export Controls on Graphite
03.10.	First Canadian Graphite Inc: First Canadian talks Volt Carbon's second U.S. patent
03.10.	First Canadian Graphite Inc.: Congratulations to Volt Carbon Technologies on Second U.S. Patent and Graphene Achievement
03.09.	First Canadian Graphite Inc: First Canadian talks up Berkwood resource estimate

Zeit

Aktuelle Nachrichten

00:18

First Canadian Graphite Inc: First Canadian talks Chinese export restrictions

First Canadian Graphite Inc.: First Canadian Graphite well positioned to Capitalize on China's Export Controls on Graphite

03.10.

First Canadian Graphite Inc: First Canadian talks Volt Carbon's second U.S. patent

03.10.

First Canadian Graphite Inc.: Congratulations to Volt Carbon Technologies on Second U.S. Patent and Graphene Achievement

03.09.

First Canadian Graphite Inc: First Canadian talks up Berkwood resource estimate

Zeit	Aktuelle Nachrichten
17.10.	JBS breaks ground on Iowa sausage plant: Company plans to invest $135 million in Iowa facility
14.10.	BMO Capital lowers JBS stock price target to $17 on weaker outlook
14.10.	JBS N.V. - 6-K, Report of foreign issuer
08.10.	JBS Returns To Paraguay With $70m Investment, Including Plant Purchase
06.10.	JBS N.V. - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

17.10.

JBS breaks ground on Iowa sausage plant: Company plans to invest $135 million in Iowa facility

14.10.

BMO Capital lowers JBS stock price target to $17 on weaker outlook

14.10.

JBS N.V. - 6-K, Report of foreign issuer

08.10.

JBS Returns To Paraguay With $70m Investment, Including Plant Purchase

06.10.

JBS N.V. - 6-K, Report of foreign issuer

Zeit	Aktuelle Nachrichten
29.08.	Rakovina Therapeutics reports Q2 results
29.08.	Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update	VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies... ► Artikel lesen
26.08.	Rakovina Therapeutics Inc: Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
12.08.	Rakovina Therapeutics Inc (2): Rakovina Therapeutics signs LOI for JV with NanoPalm
12.08.	Rakovina Therapeutics Inc: Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies	VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company... ► Artikel lesen

Zeit

Aktuelle Nachrichten

29.08.

Rakovina Therapeutics reports Q2 results

29.08.

Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies...
► Artikel lesen

26.08.

Rakovina Therapeutics Inc: Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis

12.08.

Rakovina Therapeutics Inc (2): Rakovina Therapeutics signs LOI for JV with NanoPalm

12.08.

Rakovina Therapeutics Inc: Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies

VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company...
► Artikel lesen

Zeit	Aktuelle Nachrichten
16.10.	VIRGIN AUSTRALIA HOLDINGS LIMITED: Appendix 3Y - Warne
07.10.	VIRGIN AUSTRALIA HOLDINGS LIMITED: Notification regarding unquoted securities - VGN
07.10.	VIRGIN AUSTRALIA HOLDINGS LIMITED: Appendix 3Y - Emerson
07.10.	VIRGIN AUSTRALIA HOLDINGS LIMITED: Notification regarding unquoted securities - VGN
01.10.	VIRGIN AUSTRALIA HOLDINGS LIMITED: 2025 Notice of Annual General Meeting

Zeit

Aktuelle Nachrichten

16.10.

VIRGIN AUSTRALIA HOLDINGS LIMITED: Appendix 3Y - Warne

07.10.

VIRGIN AUSTRALIA HOLDINGS LIMITED: Notification regarding unquoted securities - VGN

07.10.

VIRGIN AUSTRALIA HOLDINGS LIMITED: Appendix 3Y - Emerson

07.10.

VIRGIN AUSTRALIA HOLDINGS LIMITED: Notification regarding unquoted securities - VGN

01.10.

VIRGIN AUSTRALIA HOLDINGS LIMITED: 2025 Notice of Annual General Meeting

Unternehmen / Aktien	Kurs	%
CARIS LIFE SCIENCES INC	26,800	-2,19 %
CELLECTAR BIOSCIENCES INC	4,000	+6,67 %
CRESCENT BIOPHARMA INC	10,200	-0,97 %
FIH MOBILE LTD	2,060	+3,52 %
FIRST CANADIAN GRAPHITE INC	0,104	-16,47 %
JBS NV	11,100	-0,89 %
RAKOVINA THERAPEUTICS INC	0,164	-0,30 %
VIRGIN AUSTRALIA HOLDINGS LIMITED	1,830	-4,69 %

Unternehmen / Aktien

Kurs

CARIS LIFE SCIENCES INC

26,800

-2,19 %

CELLECTAR BIOSCIENCES INC

4,000

+6,67 %

CRESCENT BIOPHARMA INC

10,200

-0,97 %

FIH MOBILE LTD